Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9/ NOTCH/ DDR axis in pancreatic ductal adenocarcinoma. This evidence concerns the gene MYH9 and pancreatic ductal adenocarcinoma.